E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/27/2012 in the Prospect News Structured Products Daily.

New Issue: Barclays prices $2 million notes linked to five health-care stocks

By Angela McDaniels

Tacoma, Wash., April 27 - Barclays Bank plc priced $2 million of 0% notes due Oct. 30, 2013 linked to the performance of a basket of common stocks, according to a 424B2 filing with the Securities and Exchange Commission.

The equally weighted basket includes Aetna Inc., Cigna Corp., Humana Inc., UnitedHealth Group Inc. and Wellpoint, Inc.

If the final basket level is greater than the initial basket level, the payout at maturity will be par plus two times the basket return, subject to a maximum return of 25%. If the final basket level is less than the initial basket level, investors will be fully exposed to the decline.

Barclays Capital Inc. is the agent.

Issuer:Barclays Bank plc
Issue:Notes
Underlying stocks:Aetna Inc., Cigna Corp., Humana Inc., UnitedHealth Group Inc. and Wellpoint, Inc.
Amount:$2 million
Maturity:Oct. 30, 2013
Coupon:0%
Price:Par
Payout at maturity:Par plus two times any basket gain, subject to maximum return of 25%; full exposure to any basket decline
Initial share prices:$49.36 for Aetna, $48.21 for Cigna, $88.73 for Humana, $58.87 for UnitedHealth and $70.40 for WellPoint
Pricing date:April 25
Settlement date:April 30
Agent:Barclays Capital Inc.
Fees:1.5%
Cusip:06738K4C2

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.